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Abstract
Background: The etiology of Kashin-Beck disease (KBD), an endemic osteochondropathy, is largely unknown. Matrix
metalloproteinase-1 (MMP-1) plays a central role in the initiation and progression of cartilage destruction; however,
no study has reported on the relationship between KBD and MMP-1. This study was to investigate the role of
MMP-1 in the pathogenesis and progression of KBD.
Methods: Single nucleotide polymorphism (SNP) genotyping was conducted for 274 KBD cases and 248 healthy
controls using the Sequenom MassARRAY system. Additionally, the expression of MMP-1 in the knee articular
cartilage of 22 KBD patients and 21 controls was analyzed by immunohistochemistry, and the concentration of
MMP-1 in their joint fluid was also measured by enzyme-linked immunosorbent assay (ELISA).
Results: The results showed that two SNPs (rs470221 and rs1144396) had a weak association with increased
KBD risk; however, the significance of these results did not survive Bonferroni’s correction. Moreover, the
percentages of cells expressing MMP-1 in each layer of cartilage were significantly higher in the KBD group
than in the controls (F = 11.41–28.31, P = 0.002–0.000). The concentration of MMP-1 in KBD joint fluid was
significantly higher than that in the controls (t = 9.83, P < 0.0001).
Conclusions: The increased expression of MMP-1 has a potential effect on the risk of KBD in the northwest
Chinese Han population. However, six selected SNPs in the MMP-1 gene might not be useful as significant
markers for predicting KBD susceptibility in Chinese Han population. Therefore, future studies in the
association of MMP-1 with KBD should focus on other candidate SNPs.
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Background
Kashin-Beck disease (KBD) is a chronic osteochondropa-
thy affecting the bones and joints that is endemic to
certain geographical areas. According to the 2010 Health
Statistical Year Book of China, the KBD-affected area in
China covers 366 counties of 14 provinces or autono-
mous regions encompassing more than 690,000 KBD
patients and a population of 10.584 million individuals
at high risk of developing the disease. A key pathological
feature of KBD is chondrocyte necrosis in the deep zone
of the growth plate of cartilage and articular cartilage
[1, 2]. Clinically, the disease usually presents in child-
hood, between 5 and 13 years of age, and mainly at-
tacks the growth plate cartilage. KBD presents as
dwarfism, very short upper limbs, and deformed and
painful joints. The most frequently affected sites are
the distal limb joints (e.g., ankles, knees, wrists, and
elbows). Following cartilage damage, atrophied mus-
cles occur due to joint pain and limited mobility;
these deformed joints make manual farming work more
difficult and painful.
The etiology of KBD remains unclear; over the past
150 years, three environmental hypotheses have been
proposed: selenium deficiency, mycotoxins from con-
taminated storage grains, and organic matter (e.g., fulvic
acid or FA) in drinking water [3–5]. However, these the-
ories cannot account for the variable differences in the
occurrence of KBD among residents exposed to the
same environmental risk factors [6]. In our previous
study, we found that the incidence of KBD occurred in
familial clusters and that 35.10 % of cases could be at-
tributed to the polymorphic variations of KBD [7]. Cer-
tain susceptibility genes may affect susceptibility to
environmental factors, such as selenium deficiency or
other biologic factors [8, 9]. The role of matrix metallo-
proteinases (MMPs) in the degradative events invoked in
the cartilage and bone of arthritic joints has long been
appreciated [10, 11]. In a previous association analysis,
we indicated that gene markers near locus D11S4094
should be further studied [9]. The gene coding for
MMP-1 (11q22-q23) is near D11S4094 (11q23); studies
on the MMP family have shown that MMP-1 may play a
central role in the initiation and progression of cartilage
destruction [12, 13]. However, to the best of our know-
ledge, no study has reported on the relationship between
KBD and MMP-1. In this study, for the first time, we
evaluated whether MMP-1 has a potential effect on the
risk and progression of KBD.
Methods
Study population
In total, 522 unrelated Chinese Han individuals were
included in the current study; these individuals were
from KBD-endemic areas of the Linyou and Yongshou
counties of Shaanxi province, in northwest China. This
group consisted of 274 KBD patients and 248 healthy
controls. Radiographs of the right hand were taken for
both the KBD patients and the healthy controls and read
by veteran orthopedists. KBD was diagnosed according
to the national diagnostic criteria of China (WS/T 207-
2010), which are based on radiographic examination
(i.e., an X-ray of the right hand) and clinical diagnosis
(from degree I to III). Patients with clinical symptoms or
radiographic changes associated with other types of
osteochondropathy were excluded. A healthy case was
defined as no KBD and no primary or secondary osteo-
arthritis (OA). The controls were randomly selected and
were frequency-matched by age and sex. Fresh blood
(5 mL) was collected from the antecubital vein of all 522
subjects while in a fasting state.
Knee articular cartilage and synovial joint fluids were
collected from 22 KBD patients and 21 healthy controls.
The KBD patients, consisting of ten males and 12
females with an average age of 51.00 ± 8.30 (32–66)
years, underwent knee debridement or arthroplasty at a
hospital. The healthy control subjects, consisting of 11
males and ten females with an average age of 48.23 ±
7.65 (33–61) years, had no history of osteochondropathy,
but they had undergone amputation because of traffic
accidents. No significant differences were observed
between KBD and control group in age (t = 1.13, P >
0.05) and sex (x2 = 0.21, P > 0.05). None of the KBD pa-
tients or controls was diagnosed with bone or cartilage
genetic diseases or rheumatoid arthritis (RA).
The study was performed in accordance with the
Declaration of Helsinki and approved by the Human
Ethics Committee of Xi’an Jiaotong University, People’s
Republic of China. Written informed consent was also
obtained from the subjects or their relatives.
SNPs selection and genotyping
This study evaluated six single nucleotide polymor-
phisms (SNPs) of MMP-1; we selected SNPs across
the gene loci to ensure a high density of markers and
to provide an adequate characterization of haplotype
diversity. The selected SNPs were required to have an
r2 threshold of 0.8 and minor allele frequency (MAF)
≥5 % in the Chinese Han population [14] (Table 1).
Genomic DNA was extracted from the peripheral
blood using a blood DNA extraction kit (TIANGEN,
Beijing, China). Genotyping was performed using the
Sequenom MassARRAY system. Primers were de-
signed using Sequenom SNP Assay Design software
version 3.0 for iPLEX reactions. The protocol and
reaction conditions were in accordance with the
manufacturer [15]. Data management and analysis
were conducted by Sequenom Typer 4.0 Software.
Shi et al. Journal of Orthopaedic Surgery and Research  (2016) 11:64 Page 2 of 7
Immunohistochemistry
The cartilage tissues were immediately fixed in 4 % (w/v)
paraformaldehyde following collection, washed in
phosphate-buffered saline (PBS), decalcified, embedded
in paraffin, and cut into 5–8-μm-thick slices for immu-
nohistochemistry and hematoxylin and eosin (HE) stain-
ing. Immunochemical identification was performed
using the streptavidin-peroxidase (SP) method. Briefly,
after deparaffinization, endogenous peroxidase was
blocked with 3 % H2O2 for 15 min, after which the slides
were washed with PBS. The slides were then predigested
using a digestive complex followed by rinsing with PBS.
After blocking using 10 % normal goat serum, the
sections were incubated with a primary antibody recog-
nizing MMP-1 at 1:100 dilution (polyclonal rabbit anti-
MMP-1, Bioss Co, Beijing, China) or with PBS, serving
as a negative control, at 4 °C overnight. Next, the sec-
tions were incubated with 1:200 biotinylated goat anti-
rabbit IgG (ZSGB-Bio Co, Beijing ,China) at 37 °C for
20 min, followed by incubation with horseradish
peroxidase-labeled streptavidin solution at 37 °C for
15 min. Color development was continued for 5 min at
room temperature using diaminobenzidine followed by
rinsing with distilled water. Counterstaining was per-
formed with hematoxylin.
The percentage of positive cells was evaluated by
counting within 10 high-magnification power fields
(40×) in six consecutive tissue sections. The level of
expression was determined using the following semi-
quantitative criteria: 0 = negative; 1+ = less than 25 % posi-
tive staining; 2+ = 25–50 % positive staining; 3+ = more
than 50 % positive staining [1].
Enzyme-linked immunosorbent assay measurement of
MMP-1 in joint fluid
The joint fluid samples were dispensed into 1-ml ali-
quots that were treated with 50 ug/ml of hyaluronidase
for 1 h at room temperature. The joint fluid was then
diluted with diluent’s buffer to the appropriate detection
range for enzyme-linked immunosorbent assay (ELISA).
The MMP-1 level was measured using a commercial
ELISA kit (R&D System, Inc 614 McKinley Place NE,
Minneapolis, MN 55413, USA) in accordance with the
manufacturer’s manual.
Statistical analyses
The Hardy-Weinberg equilibrium (HWE) of each SNP
was tested by the goodness-of-fit x2 test to compare the
expected frequencies of genotypes in controls, SNPs
with P > 0.05 were considered to be in HWE [16]. Differ-
ences in genotypes and allele frequencies between the
KBD cases and the controls were determined using
CLUMP22 software with 10,000 Monte Carlo simula-
tions. Unconditional logistic regression analysis adjusted
for age and gender was used to estimate the strength of
the association through calculation of odds ratios (ORs)
with their 95 % confidence intervals (95 % CIs) [17].
Dominant and recessive genetic models were also evalu-
ated and expressed as ORs with 95 % CI [18]. To ac-
count for multiple testing, Bonferroni’s correction was
applied, consisting of dividing the usual significance level
of 5 % by the number of tests [17]. Differences in MMP-
1 expression in the cartilage between the two groups
were examined by analysis of variance (ANOVA) [19];
the independent-sample t test was used to compare the
concentrations of MMP-1 in joint fluid of the two




A total of 274 KBD patients and 248 age and sex
matched controls were included in the genetic poly-
morphism study. No significant differences were ob-
served between KBD and control group in age (53.37 ±
10.79 vs 51.71 ± 17.85, t = 1.29, P > 0.05) and sex (male/
female, 125/149 vs 124/124, x2 = 1, P > 0.05). In addition,
the clinical stages of the 274 KBD patients were divided
into I, II, and III stages, and the constituent ratio was
57.66 % (158/274), 31.02 % (85/274), and 11.32 % (31/
274), respectively.
Association of polymorphisms of MMP-1 with KBD
susceptibility
Table 1 showed the information of the six SNPs, all
tested SNPs were in HWE (x2 = 0.02–2.41, df = 2, P =
0.29–0.99). When the allele frequencies were compared
between the KBD cases and the controls, no significant
association was detected in the six SNPs (Table 1). The
distribution frequencies of genotypes in rs470221 and
rs1144396 were significantly different between the two
groups (Table 2). Dominant and recessive models were
applied to analyze the association between the polymor-
phisms and KBD; the ORs and 95 % CIs for KBD, as
determined from the unconditional logistic regression
Table 1 The loci information of the six SNPs in MMP-1
SNPs Allelesa SNP
location
Minor allele frequency (%) HWE test (P)
KBD Controls P values
rs2071231 T/G Intron 21.5 17.5 0.14 0.99
rs7125062 T/C Intron 15.1 15.7 0.78 0.97
rs470221 G/A Intron 33.2 29.8 0.45 0.29
rs470558 G/A Exon 18.1 16.3 0.47 0.36
rs470206 C/T 5′UTR 21.4 20.4 0.86 0.85
rs1144396 C/A 5′UTR 34.1 31.0 0.37 0.46
HWE Hardy-Weinberg equilibrium
aStands for the major/minor alleles
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models, were specifically used to evaluate the relative
risk. The SNPs rs470221 and rs1144396 showed risk
association with KBD in the recessive model (Table 2),
while the powers were calculated; the results showed
that our study had 72.4 and 67.3 % power to detect a
nominal significant finding (alpha = 0.05) in the KBD co-
hort for rs470221 and rs1144396, respectively. However,
the significance of these results did not remain after
correction for multiple testing (P > 0.05/6 = 0.008).
Expression of MMP-1 in articular cartilage and levels of
MMP-1 in joint fluids of two groups
Microscope observation revealed that MMP-1 staining was
distributed throughout all zones in the articular cartilages
of KBD patients and healthy controls. Starting from the
uppermost layer, the percentage of chondrocytes showing
MMP-1 staining decreased in each successive layer of cells.
In contrast, in the negative-control articular cartilage,
MMP-1 was not visualized (Fig. 1). A summary of the levels
of MMP-1 expression in cartilage from KBD patients and
controls is presented in Table 3. In each layer of the articu-
lar cartilage, the KBD cases showed a higher level of MMP-
1 positive staining (Fig. 1, Table 3). A comparison of the
positive rate of MMP-1 stained cells in different layers be-
tween the two groups showed that the percentages of
stained cells in the KBD group were significantly higher
than those in the controls in the upper, middle, and deeper
layers (F= 14.98, 11.41, 28.31, respectively; all P < 0.05).
The joint fluid was measured by ELISA; MMP-1 levels
in KBD joint fluid were significantly higher than those in
the controls (Fig. 2). The mean ± SEM levels of MMP-1
in the joint fluids of KBD and controls were 687.95 ±
90.92 ng/ml (482–841 ng/ml) and 408.67 ± 95.31 ng/ml
(249–573 ng/ml), respectively (t = 9.83, P < 0.0001).
Discussion
KBD is an endemic OA with a specific geographical dis-
tribution. However, not all families or individuals in
endemic areas suffer from KBD. Additionally, recent
studies reported that susceptibility genes might contrib-
ute to the pathogenesis of KBD and account for an indi-
vidual’s susceptibility to KBD [20]. MMP-1 is the most
highly expressed interstitial collagenase that degrades
fibrillar collagens, which are major constituents of the
extracellular matrix (ECM) [21]. Many studies have pro-
vided evidence for an association between the MMP-1
gene and arthritis [22, 23]. KBD has been found to have
overlapping phenotypes and pathologic changes similar
to those of OA and RA [24]. The polymorphism study
of KBD is very limited; a similar study showed a signifi-
cant association between rs6910140 of COL9A1 and
KBD [15]. Used genome-wide association study (GWAS),
ITPR2, was identified as a susceptibility gene for KBD
[25]. However, none of the six selected SNPs in the MMP-
1 gene showed an association with KBD in our study; the
finding of this study was not consistent with results of
Table 2 Analysis of association of the six SNPs gene polymorphism with the risk of KBD
SNPs Genotype (%)a Recessive model Dominant model
KBD (N = 274) Controls (N = 248) P values OR (95 % CI) OR (95 % CI)
rs2071231 60.6/35.8/3.6 68.1/28.6/3.3 0.19 1.17 (0.43–3.18) 1.40 (0.97–2.02)
rs7125062 73.0/23.7/3.3 71.4/25.8/2.8 0.73 1.36 (0.48–3.87) 0.93 (0.63–1.37)
rs470221 47.8/37.9/14.3 47.6/45.2/7.2 0.02 2.12 (1.18–3.82) 0.99 (0.70–1.40)
rs470558 66.8/30.3/2.9 70.6/26.2/3.2 0.58 0.80 (0.30–2.10) 1.17 (0.87–1.69)
rs470206 60.2/36.5/3.3 63.3/32.7/4.0 0.46 0.65 (0.26–1.65) 1.12 (0.87–1.59)
rs1144396 47.0/37.8/15.2 46.4/45.2/8.4 0.04 1.96 (1.11–3.38) 0.96 (0.68–1.36)
aHomozygote of the major allele/heterozygote/homozygote of the minor allele
Fig. 1 Expression of MMP-1 in different layers of cartilage (immunohistochemistry using the SP method; original magnification ×100). a The cartilage
of a KBD. b The cartilage of a healthy control. c A negative control with PBS was used instead of the anti-MMP-1 primary antibody
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previous studies, and we think some limitations should be
considered in relation to present results: First, it is com-
mon for a genetic variant to be associated with certain
populations but not with others [26], and we failed to
investigate the role of MMP-1 in the pathogenesis and
progression of KBD in different populations. Second, the
number of SNPs was very limited in this study; the suscep-
tibility of KBD may be associated with other SNPs in the
MMP-1 gene. So we think it should not dismiss a possible
association between MMP-1 gene polymorphism and
KBD; the gene’s roles in determining the expression of
MMP-1 should be further studied, and an approach
examining the common genetic variation of the gene
should be used.
MMPs are involved in joint destruction in arthritis
and are strongly associated with the levels of inflamma-
tion. MMP-1 is more abundant and also degrades colla-
gens effectively. In the present study, the expression of
MMP-1 in articular cartilage of knee was analyzed by
immunohistochemistry; the negative control showed
negative staining, which indicated that the test was not
confounded by other factors and was reasonable. Our re-
sults showed increased expression of MMP-1 should
play a role in the pathogenesis of KBD. These results are
Table 3 Immunohistochemical expression of MMP-1 in different layers of the articular cartilage in the two groups
Articular
cartilage
Groups Level of expression Positive rate (%)
Negative + ++ +++ Mean ± SD
Upper layer Control (n = 21) 0 0 13 8 45.27 ± 20.48
KBD (n = 22) 0 0 3 19 67.02 ± 16.19*
Middle layer Control (n = 21) 0 9 7 5 35.71 ± 24.80
KBD (n = 22) 0 1 6 15 58.19 ± 18.01*
Deeper layer Control (n = 21) 6 15 0 0 3.00 ± 32.44
KBD (n = 22) 0 9 8 5 34.87 ± 27.23*
Total layers Control (n = 21) 0 12 7 2 27.92 ± 13.59
KBD (n = 22) 0 0 11 11 53.32 ± 14.58*
*P < 0.05 compared with the control group
Fig. 2 MMP-1 concentrations in synovial fluids of knees from KBD and controls. Levels of MMP-1 in KBD samples were significantly higher than
those in controls. Statistical significance was determined using t test. Result was considered to be significant at P < 0.05
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similar to those found in other degenerative joint dis-
eases, such as OA and RA. Regarding KBD, a similar
study has been reported, in which human chondrocytes
were isolated and cultured on bone matrix gelatin to
form an artificial cartilage model in vitro with or without
T-2 toxin and selenium. With exposure to the KBD risk
factors (with T-2 toxin and without selenium), Western
blotting and RT-PCR analyses showed level of MMP-1
was increased significantly after exposure of T-2 toxin;
increasing doses of T-2 toxin resulted in an increased
expression of MMP-1; selenium increased TIMP-1
expression and decreased MMP-1 expression and partly
blocked the effects of T-2 toxin on the balance between
TIMP-1 and MMPs [27]. More specifically, studies on
the expression of MMP-1 in patients with RA or OA
found that the circulating levels of MMP-1 were ele-
vated. In our study, the levels of MMP-1 in joint fluid of
knee were also detected and the data showed higher
level of MMP-1 in patients with KBD than in controls.
A previous study in the cases of the same KBD area
showed that the serum MMP-1 levels in KBD cases were
higher than those of controls, even though no significant
difference was detected [1]. All these studies showed
that elevated levels of MMP-1 in cartilage and synovium
may be a cause of degrading cartilage in the pathogen-
esis of KBD in Chinese Han population.
Tight regulation of MMP activity is critical for main-
taining a fine balance between aggrecan and collagen
anabolism and catabolism. The MMP-1 enzyme is
known as collagenase or collagenase-1, and it degrades a
broad range of substrates (e.g., collagens I, II, III, VII,
VIII, and X; gelatin; aggrecan; versican; and proteoglycan
link protein), leading to collagen network edema that
can be inhibited by TIMP-1. Articular cartilage contains
a large number of matrix macromolecules, such as pro-
teoglycan, aggrecan, and type II collagen [28, 29], which
provide elastic and strong tensile properties that resist
mechanical loading. Under normal conditions, there is a
balance between catabolism and anabolism in the ECM
in articular cartilage [30, 31]. However, certain condi-
tions, such as inflamed synovium and pannus tissue,
may disturb this balance and accelerate catabolism of
the ECM, leading to loss of ECM components from the
cartilage, thereby severely impairing ECM functionality
and causing pain and disability [32]. Studies have
reported that IL-1β and INF-α expression in the syno-
vium, and their levels in synovial fluid and serum are
significantly higher in patients with KBD than in con-
trols [1, 33]. We think that MMP-1 overexpression in-
duced by IL-1β, INF-α, and other inflammation factors
may play an important role in destroying the articular
cartilage of KBD patients.
However, there are also some limitations to this study:
the sample populations were a little small and only
MMP-1 was included in this study. And it has been re-
ported that selenium has a protective role while T-2
toxin induces cartilage matrix degradation by regulation
of MMP-1 /TIMP-1 expression; however, environmental
factors such as low Se and T-2 toxin were not analyzed
in this study. Therefore, the effect of gene-environment
interactions needs further investigation in future well-
designed high-quality studies among well-subgrouped
populations.
Conclusions
In conclusion, up-regulation of MMP-1 in the ECM
accelerates ECM catabolism, leading to matrix degrad-
ation, cartilage degeneration, and subsequent pathogen-
esis and progression of KBD. However, the six selected
SNPs in the MMP-1 gene might not be useful as signifi-
cant markers for predicting KBD susceptibility in the
northwest Chinese Han population. Therefore, analysis of
the genetic component of KBD needs further investigation.
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